CD133 identifies a human bone marrow stem/progenitor cell sub-population with a repertoire of secreted factors that protect against stroke.
The reparative properties of bone marrow stromal cells (BMSCs) have been attributed in part to the paracrine action of secreted factors. We isolated typical human BMSCs by plastic adherence and compared them with BMSC sub-populations isolated by magnetic-activated cell sorting against CD133 (CD133-derived BMSCs, CD133BMSCs) or CD271 [p75 low-affinity nerve growth factor receptor (p75LNGFR), p75BMSCs]. Microarray assays of expressed genes, and enzyme-linked immunosorbent assays (ELISAs) of selected growth factors and cytokines secreted under normoxic and hypoxic conditions demonstrated that the three transit-amplifying progenitor cell populations were distinct from one another. CD133BMSC-conditioned medium (CdM) was superior to p75BMSC CdM in protecting neural progenitor cells against cell death during growth factor/nutrient withdrawal. Intracardiac (arterial) administration of concentrated CD133BMSC CdM provided neuroprotection and significantly reduced cortical infarct volumes in mice following cerebral ischemia. In support of the paracrine hypothesis for BMSC action, intra-arterial infusion of CD133BMSC CdM provided significantly greater protection against stroke compared with the effects of CD133BMSC (cell) administration. CdM from CD133BMSCs also provided superior protection against stroke compared with that conferred by CdM from p75BMSCs or typically isolated BMSCs. CD133 identifies a sub-population of nonhematopoietic stem/progenitor cells from adult human bone marrow, and CD133BMSC CdM may provide neuroprotection for patients with stroke.
Bakondi
Benjamin
B
Department of Medicine, Stem Cell Core, University of Vermont, Colchester, Vermont 05446, USA.
Shimada
Issei S
IS
Perry
Anthony
A
Munoz
James R
JR
Ylostalo
Joni
J
Howard
Alan B
AB
Gregory
Carl A
CA
Spees
Jeffrey L
JL
D000071916:AC133 Antigen; D015703:Antigens, CD / Q000378:metabolism*; D001854:Bone Marrow Cells / Q000166:cytology / Q000378:metabolism*; D002545:Brain Ischemia / Q000517:prevention & control*; D002454:Cell Differentiation / Q000502:physiology; D015687:Cell Hypoxia / Q000502:physiology; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D017077:Culture Media, Conditioned / Q000737:chemistry / Q000494:pharmacology; D016207:Cytokines / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D005434:Flow Cytometry; D006023:Glycoproteins / Q000378:metabolism*; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism; D020411:Oligonucleotide Array Sequence Analysis; D010455:Peptides / Q000378:metabolism*; D020521:Stroke / Q000517:prevention & control*
D000071916:AC133 Antigen; D015703:Antigens, CD; D017077:Culture Media, Conditioned; D016207:Cytokines; D006023:Glycoproteins; D036341:Intercellular Signaling Peptides and Proteins; C000606023:PROM1 protein, human; D010455:Peptides; C000606024:Prom1 protein, mouse
Science. 1997 Apr 4;276(5309):71-4
9082988
Cell. 2005 Jul 1;121(7):1109-21
15989959
Blood. 2003 Feb 1;101(3):869-76
12393715
Stem Cells. 2002;20(6):530-41
12456961
Nature. 2000 Mar 9;404(6774):193-7
10724173
Lancet. 2008 May 10;371(9624):1579-86
18468541
Stem Cells. 2007 Nov;25(11):2896-902
17901396
Stroke. 2001 Apr;32(4):1005-11
11283404
Cell. 2007 Oct 19;131(2):324-36
17956733
Nat Med. 2003 Sep;9(9):1195-201
12910262
Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2480-7
16141406
Stem Cells. 2007 Mar;25(3):628-38
17110619
Circulation. 2004 Mar 30;109(12):1543-9
15023891
J Biol Chem. 2003 Jul 25;278(30):28067-78
12740383
J Pathol. 2008 Jan;214(1):3-9
18067118
Immunity. 2006 Dec;25(6):977-88
17174120
Nat Rev Immunol. 2006 Feb;6(2):93-106
16491134
Nature. 2003 Oct 23;425(6960):841-6
14574413
Front Biosci. 2008 Jan 01;13:1271-80
17981628
Nat Med. 2005 Apr;11(4):367-8
15812508
Stem Cells. 2005 Sep;23(8):1105-12
15955825
Cell Tissue Res. 2003 Oct;314(1):5-14
13680354
Stem Cells. 2007 Dec;25(12):3234-43
17901400
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14720-5
11121071
Exp Hematol. 2002 Jul;30(7):783-91
12135677
Proc Natl Acad Sci U S A. 2003 Sep 30;100 Suppl 1:11917-23
13679583
J Clin Invest. 2008 Aug;118(8):2908-16
18654668
Blood. 1993 Apr 1;81(7):1726-38
7681701
Prog Clin Biol Res. 1984;148:13-33
6379657
J Clin Oncol. 2000 Jan;18(2):307-16
10637244
Cell. 1997 Nov 28;91(5):661-72
9393859
J Clin Endocrinol Metab. 2003 Aug;88(8):3943-51
12915691
Biochem Biophys Res Commun. 2007 Mar 16;354(3):700-6
17257581
Annu Rev Cell Dev Biol. 1995;11:35-71
8689561
Blood. 2005 May 1;105(9):3512-20
15650055
Blood. 1994 Dec 15;84(12):4164-73
7994030
Radiat Res. 1961 Feb;14:213-22
13776896
Cytotherapy. 2006;8(4):315-7
16923606
J Exp Med. 2007 Aug 6;204(8):1973-87
17664288
Blood. 2006 Mar 1;107(5):1878-87
16282345
Circ Res. 2004 Aug 20;95(4):343-53
15321944
Proc Natl Acad Sci U S A. 1964 Jan;51:29-36
14104600
J Neurosci. 2007 May 9;27(19):5146-55
17494700
Blood. 2009 Jan 22;113(4):816-26
18818395
Ann N Y Acad Sci. 2007 Jun;1106:262-71
17395729
Nat Med. 1999 Mar;5(3):309-13
10086387
Blood. 2008 Mar 1;111(5):2631-5
18086871
Curr Opin Hematol. 2008 Jan;15(1):49-58
18043246
Transplantation. 1974 Apr;17(4):331-40
4150881